SecBot SecBot
Insider Buy ·Filed Sep 30, 2026

KOD

Kodiak Sciences Inc.
BULLISH
Impact 5/10
Horizonweeks Processed26d 22h ago SEC0001193125-26-409116
Insider cluster: 1 insiders, $930K total
Actionable Insight ▲ Bullish

Monitor for any upcoming clinical catalysts or partnership announcements that may have prompted this insider purchase. The CEO's recent option exercises (non-cash) combined with a 10% owner's open-market buy suggest confidence in the company's pipeline.

DirectionBullish
Confidencemedium
Horizonweeks
Latest settled — T+5d
KOD ▼ -4.27% at T+5d
LONG call ✗ call lost -4.27% · α vs SPY -5.57% · entry $98.46 → $94.26
Next anchor: T+20d in 3d
Latest observation: T+16 -22.98% FF3 residual α
Entry = T+0 close
Oct 1, 2026
via day close
T+1d
-4.07%
call -4.07% · α -4.81%
$94.45
settled 24d ago
T+5d
-4.27%
call -4.27% · α -5.57%
$94.26
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Baker Bros. Advisors LP, a director and 10% owner, purchased 15,156 shares of Kodiak Sciences at $61.21 per share for a total of $930K on September 28, 2026. This open-market conviction buy by a major insider follows the CEO's recent exercise of stock options, signaling alignment with existing shareholders.

Key Financial Metrics

Direction
buying
Total Value
$930.0K
Insiders
1

Key Facts

  • Baker Bros. Advisors LP (Director, 10% Owner) purchased 15,156 shares at $61.21 for $930K on 2026-09-28.
  • This is a single open-market purchase (code P) by a 10% owner exceeding $100K, triggering the officer/10%-owner open-market buy rule.
  • The purchase follows the CEO's exercise of 1.88 million derivative shares (mostly non-cash) on 2026-09-25.
  • No market cap data available; absolute value of $930K is material for a clinical-stage biotech.

Financial Impact

$930K open-market purchase by a 10% owner

insider ownershipdilution

Risk Factors

  • Clinical-stage biotech with no approved products; pipeline risk is high.
  • Single insider buy, not a cluster; signal strength is moderate.
  • No market cap data to assess proportionality.

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0001193125-26-409116
9 reports for KOD
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 4 of 5 best @ T+20▲ +17.99%Jun 11, 2026
Filters
Rows
Reports for KOD — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
S-3ASR
BEARISH ★ 5/10
$87.72awaiting T+20—$89.60 (−2.14%)
Sep 30, 2026
26d ago
SC 13D/A
BULLISH ★ 7/10
$98.46awaiting T+20—$89.60 (−9.00%)
Sep 30, 2026
26d ago
Insider Buy
BULLISH ★ 5/10
$98.46awaiting T+20—$89.60 (−9.00%)
Sep 28, 2026
28d ago
8-K
BULLISH ★ 7/10
$89.92 $89.60▼ −0.36%▼ −0.32%$89.60 (−0.36%)
Aug 13, 2026
10w ago
8-K
NEUTRAL ★ 4/10
$41.35 $33.14▼ −19.85%▼ −17.86%$89.60 (+116.69%)
Aug 13, 2026
10w ago
Press Release
NEUTRAL ★ 6/10
$41.35 $33.14▼ −19.85%▼ −17.86%$89.60 (+116.69%)
Jun 11, 2026
19w ago
Institutional Cluster
BULLISH ★ 4/10
$33.97 $40.08▲ +17.99%▲ +16.10%$89.60 (+163.76%)
May 7, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$41.01 $31.05▼ −24.29%▼ −24.31%$89.60 (+118.48%)
Mar 31, 2026
29w ago
8-K
BULLISH ★ 8/10
$42.81 $43.67▲ +2.01%▼ −7.71%$89.60 (+109.30%)
Showing 9 of 9

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 30, 2026